drug
coagulation factor IX (recombinant), Fc fusion protein LA
Marketedupdated 3mo agoby Sanofi-Aventis US LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying coagulation factor IX (recombinant), Fc fusion protein LA
- —An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B
- —A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B
- —A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France
- phase1A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that